The efficacy of topical interferon alpha-2b in pterygium

Phase 2

• Conditions: Pterygium of eye; H11.0; pterygium.

• Registration Number: IRCT20190806044463N1
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Any patients with primary or recurrent pterygium; either unilaterally or bilaterally, who was diagnosed by an ophthalmologist

Exclusion Criteria

Use of any topical ophthalmic drug in previous six months
Patients with allergy to interferon alpha-2b
Patients with History of Refractive Surgery
History of any eye diseases other than refractive errors and pterygium
Pregnant or lactating women

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pterygium grade. Timepoint: 1- Baseline (before injection) 2- 1st month 2- 2nd month 3- 6th month. Method of measurement: Based on the degree of visibility of the epithelial vessels by an ophthalmologist.